Difei Wang
-
- Histone Deacetylase Inhibitors Research 3
- Metabolism, Diabetes, and Cancer 3
- RNA modifications and cancer 3
- DNA and Nucleic Acid Chemistry 2
-
- Diabetes Management and Research 2
- Organic Chemistry top 10%
-
- Peptidase Inhibition and Analysis 3
- Cancer-related Molecular Pathways 2
-
- Cancer-related molecular mechanisms research 2
Difei Wang
23 papers receiving 791 citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 452
- Health Informatics 8
- Endocrinology, Diabetes and Metabolism 95
- Organic Chemistry 153
- Oncology 139
Countries citing papers authored by Difei Wang
This map shows the geographic impact of Difei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Difei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Difei Wang more than expected).
Fields of papers citing papers by Difei Wang
This network shows the impact of papers produced by Difei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Difei Wang. The network helps show where Difei Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Difei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 13 | |
| 5 | 2023 | 17 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 10 | |
| 8 | 2019 | 38 | |
| 9 | 2018 | 13 | |
| 10 | 2018 | 10 | |
| 11 | 2017 | 8 | |
| 12 | 2016 | 22 | |
| 13 | 2016 | 18 | |
| 14 | 2016 | 47 | |
| 15 | 2014 | 35 | |
| 16 | 2012 | 0 | |
| 17 | 2009 | 38 | |
| 18 | 2005 | 175 | |
| 19 | 2004 | 32 | |
| 20 | 2004 | 122 |
About Difei Wang
Difei Wang is a scholar working on Health Informatics, General Materials Science and Endocrinology, Diabetes and Metabolism, having authored 26 papers that have together received 806 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Metabolism, Diabetes, and Cancer (3 papers), RNA modifications and cancer (3 papers), Diabetes Management and Research (2 papers), DNA and Nucleic Acid Chemistry (2 papers), Cancer-related Molecular Pathways (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Molecular Biology (452 citations), Health Informatics (8 citations) and Endocrinology, Diabetes and Metabolism (95 citations). Difei Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Olaf Wiest, Norbert L. Wiech, Paul Helquist, Yun‐Dong Wu, Jonathan L. Sessler, Jianqiu Gu, Yingfang Wang, Ting Huang, Fenqin Chen and Guojing Ma. Their work appears in journals such as Journal of Biological Chemistry, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.